Cargando…

Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC

BACKGROUND: Non-small cell lung cancer (NSCLC) patients with primary tumors and liver metastases have substantially reduced survival. Since mesenchymal-epithelial transition factor (MET) plays a significant role in the molecular mechanisms of advanced NSCLC, small molecule MET inhibitor capmatinib (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yige, Yang, Jie, Li, Yingbo, Luo, Jing, Sun, Jiemei, Li, Daoshuang, Wang, Yuchen, Wang, Kai, Yang, Lili, Wu, Lina, Sun, Xilin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717478/ https://www.ncbi.nlm.nih.gov/pubmed/36457016 http://dx.doi.org/10.1186/s12943-022-01681-y

Ejemplares similares

c-Met-Targeting (19)F MRI Nanoparticles with Ultralong Tumor Retention for Precisely Detecting Small or Ill-Defined Colorectal Liver Metastases
por: Li, Daoshuang, et al.
Publicado: (2023)

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
por: Qin, Shukui, et al.
Publicado: (2019)

Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model
por: Brandes, Franziska, et al.
Publicado: (2015)

INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell models
por: Moran-Jones, Kim, et al.
Publicado: (2015)

Erratum to A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
Publicado: (2020)

Multirooted supernumerary tooth in the anterior maxilla: A rare presentation
por: Ghosh, Snehashish, et al.
Publicado: (2022)

INC280 inhibits Wnt/β-catenin and EMT signaling pathways and its induce apoptosis in diffuse gastric cancer positive for c-MET amplification
por: Sohn, Sung-Hwa, et al.
Publicado: (2019)

Morphometric Analysis of Furcation Areas of Multirooted Teeth in a Tunisian Population
por: Mabrouk, Rym, et al.
Publicado: (2020)

Phase I dose‐escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors
por: Esaki, Taito, et al.
Publicado: (2019)

Assessment of Pulp Vitality in Multirooted Teeth With Advanced Periodontal Disease: A Clinical and Histological Study
por: Arulmari, Srivainavi, et al.
Publicado: (2023)

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC
por: Jie, Guang-Ling, et al.
Publicado: (2023)

Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report
por: Jiao, Yang, et al.
Publicado: (2021)

A comparative clinical evaluation of accuracy of six apex locators with intraoral periapical radiograph in multirooted teeth: An in vivo study
por: Saraf, Prahlad A., et al.
Publicado: (2017)

ZNF280BY and ZNF280AY: autosome derived Y-chromosome gene families in Bovidae
por: Yang, Yang, et al.
Publicado: (2011)

Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification
por: Sun, Dantong, et al.
Publicado: (2022)

Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy
por: Li, Yingbo, et al.
Publicado: (2021)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Yoshimura, Katsuhiro, et al.
Publicado: (2021)

Comparative analysis of KPC-2-encoding chimera plasmids with multi-replicon IncR:Inc(pA1763-KPC):IncN1 or IncFII(pHN7A8):Inc(pA1763-KPC):IncN1
por: Qu, Daofeng, et al.
Publicado: (2019)

A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
por: van den Bent, Martin, et al.
Publicado: (2019)

Real-world insights into patients with advanced NSCLC and MET alterations
por: Bittoni, Marisa, et al.
Publicado: (2021)

Microbiological Effectiveness of Sodium Hypochlorite Gel and Aqueous Solution When Implemented for Root Canal Disinfection in Multirooted Teeth: A Randomized Clinical Study
por: Kotecha, Niral, et al.
Publicado: (2023)

Clinical and pathological characteristics of 11 NSCLC patients with c-MET exon 14 skipping
por: Chen, Hualin, et al.
Publicado: (2022)

Canadian Consensus Recommendations on the Management of MET-Altered NSCLC
por: Cheema, Parneet K., et al.
Publicado: (2021)

Overcoming MET-mediated resistance in oncogene-driven NSCLC
por: Reischmann, Nadine, et al.
Publicado: (2023)

Fitness Cost of bla(NDM-5)-Carrying p3R-IncX3 Plasmids in Wild-Type NDM-Free Enterobacteriaceae
por: Ma, Tengfei, et al.
Publicado: (2020)

Team no. 280 SIN II
por: Thivent, Μ
Publicado: (1981)

Preferences and flexibility in decision-making among dental clinicians regarding the treatment of multirooted teeth: an interactive communication device-based survey at two academic conferences
por: Lee, Jung-Seok, et al.
Publicado: (2016)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
por: Liu, Li, et al.
Publicado: (2021)

A clinical KPC-producing Klebsiella michiganensis strain carrying IncFII/IncFIA (HI1)/IncFIB (K) multiple replicon plasmid
por: Zhang, Na, et al.
Publicado: (2023)

Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
por: Jørgensen, Jan Trøst, et al.
Publicado: (2022)

Limited Inc
por: Derrida, Jacques
Publicado: (1988)

Trust Inc.
por: Yeomans, Matthew
Publicado: (2018)

Fitness Advantage of mcr-1–Bearing IncI2 and IncX4 Plasmids in Vitro
por: Wu, Renjie, et al.
Publicado: (2018)

Health Tract, No. 280: Passing Away
Publicado: (1867)

Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC
por: Xiao, Zunyu, et al.
Publicado: (2017)

Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting
por: Ai, Xinghao, et al.
Publicado: (2022)

ZNF280A Promotes Proliferation and Tumorigenicity via Inactivating the Hippo-Signaling Pathway in Colorectal Cancer
por: Wang, Xu, et al.
Publicado: (2019)

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
por: Presutti, Dario, et al.
Publicado: (2015)

Devil in the detail: MET overexpression fails as surrogate marker for MET exon 14 splice site mutations in NSCLC
por: Strickland, Matthew R., et al.
Publicado: (2020)

Development and Evaluation of (18)F-IRS for Molecular Imaging Mutant EGF Receptors in NSCLC
por: Song, Yan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6ovc91jate6bnnleb6t54e8il7